Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Yann Bourhis"'
Autor:
Klemens Fheodoroff, MD, Jorge Jacinto, MD, Stephen Ashford, PhD, Natalya Danchenko, PhD, Anne-Sophie Grandoulier, MSc, Guilhem Pietri, MSc, Yann Bourhis, PharmD, Dean Spurden, PhD, Lynne Turner-Stokes, DM
Publikováno v:
The Journal of the International Society of Physical and Rehabilitation Medicine, Vol 7, Iss 1, Pp 24-32 (2024)
Background:. To explore predictors of treatment response in adults receiving botulinumtoxin-A (BoNT-A) for upper limb spasticity (ULS) and to describe the association between response and concomitant medication, professional physical therapy, and qua
Externí odkaz:
https://doaj.org/article/3c191559aa0640949b2c2ba53f49ce6f
Autor:
Nicolas Vignier, Olivier Bouchaud, Andrea Angheben, Emmanuel Bottieau, Guido Calleri, Joaquín Salas-Coronas, Charlotte Martin, José Manuel Ramos, Matthieu Mechain, Christophe Rapp, Hans-Dieter Nothdurft, Maria Velasco, Azucena Bardají, Gerardo Rojo-Marcos, Leo G. Visser, Christoph Hatz, Zeno Bisoffi, Tomas Jelinek, Stephan Duparc, Yann Bourhis, Silva Tommasini, Maurizio Iannucelli, Antonella Bacchieri, Giovan Giuseppe Mattera, Emilio Merlo Pich, Ronald H. Behrens
Publikováno v:
Malaria Journal, Vol 20, Iss 1, Pp 1-14 (2021)
Abstract Background European travellers to endemic countries are at risk of malaria and may be affected by a different range of co-morbidities than natives of endemic regions. The safety profile, especially cardiac issues, of artenimol (previously di
Externí odkaz:
https://doaj.org/article/920a0808da52452c957698e9a4d64b34
Autor:
Antonella Bacchieri, Silva Tommasini, Guido Calleri, Stephan Duparc, Hans-Dieter Nothdurft, José Ramos, Gerardo Rojo-Marcos, Joaquín Salas-Coronas, Olivier Bouchaud, Emilio Merlo Pich, Emmanuel Bottieau, Matthieu Mechain, Christoph Hatz, Maurizio Iannucelli, Nicolas Vignier, Azucena Bardají, Christophe Rapp, Leo G. Visser, Yann Bourhis, Andrea Angheben, Zeno Bisoffi, Charlotte Martin, Giovan Giuseppe Mattera, María Velasco, Ron H Behrens, Tomas Jelinek
Publikováno v:
Malaria Journal, Vol 20, Iss 1, Pp 1-14 (2021)
Malaria journal, 20 (1
Malaria Journal
Malaria Journal, BioMed Central, 2021, 20 (1), pp.214. ⟨10.1186/s12936-021-03750-x⟩
MALARIA JOURNAL
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
Malaria Journal, 20(1). BMC
Malaria journal, 20 (1
Malaria Journal
Malaria Journal, BioMed Central, 2021, 20 (1), pp.214. ⟨10.1186/s12936-021-03750-x⟩
MALARIA JOURNAL
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
Malaria Journal, 20(1). BMC
Background: European travellers to endemic countries are at risk of malaria and may be affected by a different range of co-morbidities than natives of endemic regions. The safety profile, especially cardiac issues, of artenimol (previously dihydroart
Autor:
Jorge Jacinto, Stephen Ashford, Klemens Fheodoroff, Natalya Danchenko, Françoise Calvi-Gries, Yann Bourhis, John Whalen, Lynne Turner-Stokes
Publikováno v:
Toxicon. 214:S26-S27
Autor:
Jean Claude Mbanya, Juliana C.N. Chan, Jean-Marc Chantelot, Marina Vladimirovna Shestakova, Juan José Gagliardino, Hasan Ilkova, Pablo Aschner, Fernando Lavalle, Ambady Ramachandran, Yann Bourhis
Publikováno v:
Diabetes Care
SEDICI (UNLP)
Universidad Nacional de La Plata
instacron:UNLP
SEDICI (UNLP)
Universidad Nacional de La Plata
instacron:UNLP
Objetive: Depression is common in people with diabetes, but data from developing countries are scarce. We evaluated the prevalence and risk factors for depressive symptoms in patients with diabetes using data from the International Diabetes Managemen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e97f53f014e2771d84664fb9f60e02a7
https://doi.org/10.2337/figshare.14098679
https://doi.org/10.2337/figshare.14098679
Autor:
Nicoletta Colombo, Isabel Bover, Linda Van Le, C. Blakeley, Gloria S. Huang, Sudeep Karve, Sharad A. Ghamande, Andrew Green, Yann Bourhis, Philippe Huot-Marchand, Eva Chalas, Santiago González-Santiago, Begoña Graña Suárez, James Fiorica, Sandro Pignata, Giovanni Scambia
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 36(13)
Purpose There is a growing demand for BRCA1/ 2 mutation ( BRCAm) testing in patients with ovarian cancer; however, the limited number of genetic counselors presents a potential barrier. To facilitate more widespread BRCAm testing in ovarian cancer, p
Autor:
Elisabeth, Cassuto, Georges P, Pageaux, Diego, Cantarovich, Lionel, Rostaing, Alexandre, Loupy, Bruno, Roche, Christophe, Duvoux, Karine, Moreau, Eric, Thervet, Hakim, Mazouz, Yann, Bourhis, Sébastien, Dharancy, Michèle, Kessler, François, Chantrel
Publikováno v:
Transplantation. 100(10)
Adherence to immunosuppressive treatments is a major concern in transplanted patients.This 6-month French observational, longitudinal, prospective study aimed to assess patient adherence to and acceptance of once-daily tacrolimus (Advagraf) initiatio
Publikováno v:
Revue Neurologique. 173:S123-S124
Introduction ACCEPT est un auto-questionnaire valide mesurant l’acceptance des patients pour leur traitement. L’acceptance est definie comme la balance entre avantages et inconvenients d’un traitement, evaluee par le patient lui-meme. Objectifs
Publikováno v:
Journal of Membrane Science. 207:265-272
Protein binding of drug is responsible of ineffectiveness of conventional hemodialysis. The aim of the present study was to investigate the potential of electrodialysis, i.e. the transport of charged solutes through a membrane under the influence of
Autor:
C. Blakeley, Sudeep Karve, Eva Chalas, James Fiorica, Giovanni Scambia, Philippe Huot-Marchand, Linda Van Le, Yann Bourhis, Santiago Gonzalez Santiago, Sharad A. Ghamande, Gloria S. Huang, Andrew Emmons Green, Begoña Graña Suárez, Nicoletta Colombo, Isabel Bover, Sandro Pignata
Publikováno v:
Journal of Clinical Oncology. 35:5559-5559
5559 Background: Short BRCAm testing turnaround times (TAT) are crucial to making timely treatment decisions for patients (pts) with ovarian cancer. ENGAGE (NCT02406235; D0816R00006) evaluated a streamlined, oncologist-led germline BRCAm testing mode